A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
Clinical trial NCT07638683 · RECRUITING
Trial details
- NCT number
- NCT07638683
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-22
- Primary completion
- 2028-07-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.